Stock DNA
Pharmaceuticals & Biotechnology
CNY 4,348 Million (Small Cap)
13.00
NA
3.56%
-0.18
13.45%
1.78
Revenue and Profits:
Net Sales:
803 Million
(Quarterly Results - Jun 2025)
Net Profit:
102 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
6.02%
0%
6.02%
6 Months
-6.11%
0%
-6.11%
1 Year
-4.53%
0%
-4.53%
2 Years
-17.31%
0%
-17.31%
3 Years
7.39%
0%
7.39%
4 Years
10.94%
0%
10.94%
5 Years
12.1%
0%
12.1%
Zhuzhou Qianjin Pharmaceutical Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0.01%
EBIT Growth (5y)
-2.82%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.23
Sales to Capital Employed (avg)
1.35
Tax Ratio
8.57%
Dividend Payout Ratio
65.29%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
28.21%
ROE (avg)
15.82%
Valuation key factors
Factor
Value
P/E Ratio
13
Industry P/E
Price to Book Value
1.78
EV to EBIT
14.01
EV to EBITDA
9.94
EV to Capital Employed
1.95
EV to Sales
1.12
PEG Ratio
NA
Dividend Yield
3.56%
ROCE (Latest)
13.94%
ROE (Latest)
13.45%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Sideways
Moving Averages
Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
Jun'25
Jun'24
Change(%)
Net Sales
803.20
914.50
-12.17%
Operating Profit (PBDIT) excl Other Income
122.50
121.70
0.66%
Interest
0.00
0.50
-100.00%
Exceptional Items
0.30
1.90
-84.21%
Consolidate Net Profit
101.70
88.10
15.44%
Operating Profit Margin (Excl OI)
117.20%
98.70%
1.85%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2025 is -12.17% vs -3.05% in Jun 2024
Consolidated Net Profit
YoY Growth in quarter ended Jun 2025 is 15.44% vs 0.57% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
3,591.50
3,760.50
-4.49%
Operating Profit (PBDIT) excl Other Income
401.40
498.20
-19.43%
Interest
8.50
6.00
41.67%
Exceptional Items
3.60
-1.60
325.00%
Consolidate Net Profit
302.60
395.00
-23.39%
Operating Profit Margin (Excl OI)
78.20%
100.00%
-2.18%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -4.49% vs -5.71% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -23.39% vs 2.04% in Dec 2023
About Zhuzhou Qianjin Pharmaceutical Co., Ltd. 
Zhuzhou Qianjin Pharmaceutical Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






